Paragonix Technologies’ $24 Million Series B Investment

Sheppard Mullin advised Signet Healthcare Partners on the deal.Paragonix Technologies, Inc., a leading organ transplant company, announced that it has secured $24 million in Series B…

This content is for Standard 1 Year members only.
Login Join Now
Martina Bellini

Author: Martina Bellini

This content is for Standard 1 Year members only.
Login Join Now